GPT and Cirrhosis: In keeping with previous cohorts, APRI had a poor sensitivity for cirrhosis, with 6 of 12 individuals with cirrhosis on ultrasound also having an APRI >2.27 By relying on just ALT, APRI and HBV DNA without ultrasound, six individuals with significant liver disease would not have been offered treatment.